📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Covagen

1.1 - Company Overview

Covagen Logo

Covagen

Headquarter: Switzerland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of bispecific FynomAbs by fusing human Fynomer binding proteins to antibodies, creating protein-based therapeutics with novel modes of action and enhanced efficacy for the treatment of inflammatory diseases and cancer; ability to fuse Fynomers to multiple antibody sites enables tailored architectures.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Covagen

SynDevRx Logo

SynDevRx

HQ: United States Website
  • Description: Provider of polymer-based drug conjugates for oncology, including evexomostat (SDX-7320), a polymer-drug conjugate that releases a fumagillol derivative in vivo to target cancer and systemic metabolic hormone dysfunction. Sponsors clinical trials across various cancer types, provides an expanded access program, and advances a pipeline focused on cancers sensitive to metabolic hormones, leveraging metabo-oncology and polymer-drug conjugation to improve safety and activity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SynDevRx company profile →
4P Therapeutics Logo

4P Therapeutics

HQ: United States Website
  • Description: Provider of research and development of novel drug delivery technologies and therapeutics, developing pharmaceutical products from pre-clinical testing to clinical manufacturing, with a focus on meeting the needs of patients, physicians and payers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 4P Therapeutics company profile →
Amerita Logo

Amerita

HQ: United States Website
  • Description: Provider of specialty infusion services focused on delivering complex pharmaceutical products and clinical services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amerita company profile →
Senda Biosciences Logo

Senda Biosciences

HQ: United States Website
  • Description: Provider of a therapeutics platform leveraging insights into molecular connections between humans, offering Endless RNA (eRNA) to program proteins inside the body with long-lasting expression, Natural NanoParticle (NNP) technology with nanoparticles derived from nature for targeted delivery of biomolecules into human cells, and AI-driven integrative design of RNA medicines for oncology and rare diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Senda Biosciences company profile →
OncoZenge Logo

OncoZenge

HQ: Sweden Website
  • Description: Provider of supportive care products for cancer patients. Swedish pharmaceutical company developing BupiZenge™, a lozenge designed to provide local pain relief for oral mucositis, a common side effect of radiotherapy and chemotherapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OncoZenge company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Covagen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Covagen

2.2 - Growth funds investing in similar companies to Covagen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Covagen

4.2 - Public trading comparable groups for Covagen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Covagen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Covagen

What does Covagen do?

Covagen is a provider of bispecific FynomAbs by fusing human Fynomer binding proteins to antibodies, creating protein-based therapeutics with novel modes of action and enhanced efficacy for the treatment of inflammatory diseases and cancer; ability to fuse Fynomers to multiple antibody sites enables tailored architectures.

Who are Covagen's competitors?

Covagen's competitors and similar companies include SynDevRx, 4P Therapeutics, Amerita, Senda Biosciences, and OncoZenge.

Where is Covagen headquartered?

Covagen is headquartered in Switzerland.

How many employees does Covagen have?

Covagen has 1,000 employees 🔒.

When was Covagen founded?

Covagen was founded in 2010 🔒.

What sector and industry vertical is Covagen in?

Covagen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Covagen

Who are the top strategic acquirers in Covagen's sector and industry

Top strategic M&A buyers and acquirers in Covagen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Covagen?

Top strategic M&A buyers groups and sectors for Covagen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Covagen's sector and industry vertical

Which are the top PE firms investing in Covagen's sector and industry vertical?

Top PE firms investing in Covagen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Covagen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Covagen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Covagen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Covagen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Covagen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Covagen?

The key public trading comparables and valuation benchmarks for Covagen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Covagen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Covagen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Covagen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Covagen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Covagen's' sector and industry vertical?

Access recent funding rounds and capital raises in Covagen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Covagen